Latest filing published 13 Feb 2024 for Palisade Bio, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Robert J. Trenschel in Palisade Bio, Inc., where the filings describe the role as board member. The record holds 3 filings, for trades running from 31 August 2021 to 8 February 2024.
Market trades split into 1 purchase (€4,075) and 1 sale (€180). Taken together, the purchases exceed the sales by €3,894. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 option exercise.
The newest entry dates from 13 February 2024: an option exercise, in Palisade Bio, Inc. The last purchase on record was published on 13 September 2021, which is 1,861 days ago. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations